changing from tirzepatide to retatrutide How Switch To Switching from Tirzepatide to Retatrutide?

Disproportionality signals for IGE All five GLP-1RAs had statistically significant reporting odds ratios (RORs) for IGE: Semaglutide: ROR 24.8 Dulaglutide: ROR 14.7 Liraglutide: ROR 13.7 Exenatide: ROR 5.4 Tirzepatide: ROR 18.3 This analysis confirms that these drugs are significantly more likely to be reported in conjunction with IGE compared to other medications

Those predisposed to kidney stone formation may consider avoiding high-dose (1 g/day) vitamin C supplementation

Because infant GI tracts are still developing and their metabolic pathways differ significantly from adults, exposure to GLP-1 agonists carries theoretical risks of altered feeding patterns, hypoglycemia, and delayed gastric function in nursing babies

Researchers stated that more study is needed